Showing results (91-100 of 677) with videos related to
Sort By:
Pageof 68
Oncogene|January 16, 2004
Effect of merlin phosphorylation on neurofibromatosis 2 (NF2) gene functionEzequiel I Surace, Carrie A Haipek, David H GutmannDevelopmental Medicine and Child Neurology|August 29, 2017
Neurodevelopmental disorders in children with neurofibromatosis type 1Alecia C Vogel, David H Gutmann, Stephanie M MorrisNeuro-Oncology|August 29, 2014
The mTOR signaling pathway as a treatment target for intracranial neoplasmsDoreen Pachow, Wolfgang Wick, David H Gutmann, et al.Genes & Development|August 15, 2015
Neurofibromatosis-1 regulation of neural stem cell proliferation and multilineage differentiation operates through distinct RAS effector pathwaysYi-Hsien Chen, Scott M Gianino, David H GutmannCancer Epidemiology|March 29, 2016
Peri-gestational risk factors for pediatric brain tumors in Neurofibromatosis Type 1Kimberly J Johnson, Nancy L Zoellner, David H GutmannJournal of Child Neurology|September 2, 2016
Macrocephaly Is Not a Predictor of Optic Pathway Glioma Development or Treatment in Neurofibromatosis Type 1Stephanie M Morris, Courtney L Monroe, David H GutmannJournal of Attention Disorders|February 23, 2012
A neuropsychological perspective on attention problems in neurofibromatosis type 1Alexandra K Templer, Jeffrey B Titus, David H GutmannThe Journal of Clinical Investigation|April 6, 2006
Harnessing preclinical mouse models to inform human clinical cancer trialsDavid H Gutmann, Kim Hunter-Schaedle, Kevin M ShannonCancer Research|January 7, 2006
Mouse Models of Human Cancers Consortium Workshop on Nervous System TumorsDavid H Gutmann, Elizabeth A Maher, Terry Van DykeCancer Research|January 25, 2005
Glioma formation in neurofibromatosis 1 reflects preferential activation of K-RAS in astrocytesBiplab Dasgupta, Wen Li, Arie Perry, et al.Pageof 68